ISSN 1673-3770 CN 37-1437/R
山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (2): 28-31.doi: 10.6040/j.issn.1673-3770.1.2016.08
邱杰,孙彦
QIU Jie, SUN Yan
中图分类号:
| [1] Swierniak M, Wojcicka A, Czetwertynska M, et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma[J]. J Clin Endocrinol Metab., 2013, 98(8):1401-1409. [2] Network CGAR: Integrated genomic characterization of papillary thyroid carcinoma[J]. Cell, 2014, 159(3):676-690. [3] Qiu J, Zhang W W, Xia Q S, et al. RNA Sequencing identifies crucial genes in papillary thyroid carcinoma(PTC)progression[J]. Exp Mol Pathol, 2016, 100(1):151-159. [4] Kushchayeva Y, Jensen K, Burman J K, et al. Repositioning therapy for thyroid cancer: new insights on established medications[J]. Endocr Relat Cancer, 2014, 21(3):183-194. [5] Essig G F Jr, Porter K, Schneider D, et al. Fine needle aspiration and medullary thyroid carcinoma:the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone[J]. Endocr Pract, 2013, 19(6):920-927. [6] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3):157-164. [7] Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, et al. Predictive factors that influence the course of medullary thyroid carcinoma[J]. Int J Clin Oncol, 2014, 19(3):445-451. [8] Barbet J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubing-times in patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab, 2005, 90(11):6077-6084. [9] Bugalho M J, Santos J R, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement[J]. J Surg Oncol, 2005, 91(1):56-60. [10] Camacho C P, Lindsey S C, Melo M C, et al. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests[J]. Thyroid, 2013, 23(3):308-316. [11] Wimalawansa S J. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma[J]. J Bone Miner Res, 1993, 8(4):467-473. [12] Yap N S-J,Maher R, Learoyd D C. Any detectable thyroglobulin in lymph node biopsy washouts suggests local recurrence in differentiated thyroid cancer[J]. Endocr Connect, 2014, 3(1):150-155. [13] Milas M, Bsrbosa G F, Mitchell J, et al. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer[J]. Ann Surg Oncol, 2009, 16(2):473-480. [14] Ersoz S, Sert H, Yandi M, et al. The significance of galectin-3 expression in immunocytochemical evaluation of thyroid fine needle aspiration cytology[J]. Pathol Oncol Res, 2008, 14(4):457-460. [15] Paunovic I, Isic T, Havelka M, et al. Combined immunohistochemistry for thyroid peroxidase, Galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors[J]. APMIS, 2012, 120(5):368-379. [16] Ma H,Xu S, Yan J, et al. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination[J]. Pol J Pathol, 2014, 65(3):202-209. [17] Liu Z, Li X, Shi L, et al. Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma[J]. Int J Clin Exp Med, 2014, 7(8):2304-2308. [18] Calangiu C M, Simionescu C E, Stepan A E, et al. The expression of CK19, vimentin and E-cadherin in differentiation thyroid carcinomas[J]. Rom J Morphol Embryol, 2014, 55(3):919-925. [19] Tian X, Cong M, Zhou W, et al. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer[J]. J Int Med Res, 2008, 36(4):699-703. |
| [1] | 方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73. |
| [2] | 雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67. |
| [3] | 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73. |
| [4] | 卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94. |
| [5] | 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111. |
| [6] | 程卓, 梁辉, 邢鲁民. 深度学习技术在咽喉内镜应用中的研究进展及前景分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 112-119. |
| [7] | 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141. |
| [8] | 马孝宝,沈佳丽,杨军,陈建勇,朱颂欢. 水平半规管扫视波的临床意义探究[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 40-45. |
| [9] | 刘梓琪,黄佳丽,汪李琴,陈曦,张立庆,周涵. 窄带成像内镜联合嗓音声学分析在声带白斑鉴别诊断中的价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 87-96. |
| [10] | 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137. |
| [11] | 韩鑫宇,陈钢钢,李莹,周丽媛,杨捷,吴佳鑫,李育军. 双侧前庭病的非药物治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 154-159. |
| [12] | 王晓杰,张明君,宋哲莹,崔丽梅,宋西成. 山奈酚抗癌的作用机制及研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 168-178. |
| [13] | 刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25. |
| [14] | 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33. |
| [15] | 刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100. |
|
||